Episodes

This episode features Scott Stout, who is helping reshape clinical trial recruitment through MedVector’s innovative HCP Recruitment model. By engaging community physicians in a new way, MedVector enables access to larger and more diverse patient populations for clinical trial sites. Their approach allows trusted healthcare providers and their patients to benefit from clinical trials as a care option—without requiring physicians to become investigators or risking patient leakage. By aligning provider incentives, MedVector opens access to millions of patients who are traditionally excluded from clinical research. In this episode, we discuss the challenges of patient recruitment, the importance of diversity in clinical trials, and how MedVector is redefining provider participation in clinical research.

This episode features Matteo Talotta, a global leader with experience across banking, academia, government, and a wide range of organizations — from start-ups and scale-ups to large multinationals. After working in Canada, Italy, the U.S., Spain, and Romania, Matteo brings a rich, multicultural perspective to the world of clinical innovation. Fluent in four languages and driven by collaboration, his career has led him to focus on the transformative power of AI in biotechnology. He is currently part of Biorce, an AI-powered organization redefining how the pharmaceutical industry, biotech companies, hospitals, and clinical trial teams develop new therapies. Their goal: to make breakthrough treatments more accessible and affordable by uniting advanced technology with human insight.

In this episode, we’re joined by Sonal Pendharkar Kulkarni, Ph.D., Co-founder and Chief Science Officer at Uvisa Health. With a background that bridges women’s health, the microbiome, digital health innovation, and medical device development, Sonal is at the forefront of creating smarter, science-driven solutions for vaginal health management. Sonal shares her journey from research scientist to entrepreneur, the insights that shaped Uvisa Health’s mission, and the importance of designing products that truly respond to women’s real needs. We explore her multidisciplinary approach—combining clinical research, product design, and technology—to rethink how women’s health challenges are understood and addressed.

In this episode, we sit down with David M. Kraemer, Founder of a boutique investment bank and former Vice President at Merrill Lynch and Wilshire Consulting. With deep experience across public and private markets, David shares insights on capital formation, innovation, and navigating complex investment landscapes.  From biotech and MedTech to AI, robotics, and venture capital, his perspective bridges finance and technology in today’s fast-changing world. Tune in to hear how he’s built global partnerships and what drives his success in the ever-evolving world of investment and entrepreneurship.

Dr. Palumbo is a physician-scientist with 30+ years leading programs in psychiatry, neurology, and neurodegenerative disease across Johnson & Johnson/Janssen, Mitsubishi Tanabe, Zynerba, and BioVie, with contributions to FDA registrations such as Risperdal Consta, Invega, Invega Sustenna, and Radicava. He emphasizes the formative role of early mentors and cross-disciplinary collaboration throughout his path from medical training at George Washington University and Yale into industry leadership.[1] - Trends in clinical research: He highlights rising diversity in the field and the value of multi-disciplinary talent (engineers-physicians-scientists) enabling systems biology approaches. He notes a positive shift toward starting with the right scientific questions and then applying technology (including AI) as a tool, rather than leading with tools. He also underscores the growing power of patient advocacy in steering research priorities toward real unmet needs across areas such as vacc…

- Guest: Nicholas Kadysh, CEO of PharmAla Biotech, a company pioneering GMP-grade MDMA production and recognized as a top-performing Canadian market stock in 2023. He also serves as Chair of Psychedelics Canada, leading efforts to strengthen legal and ethical standards and advance government engagement and policy in the psychedelic medicine sector. - Core themes: - Biotech innovation in psychedelic-assisted therapies, with a focus on pharmaceutical-grade MDMA manufacturing and compliance. - The evolving future of psychedelic medicine, including clinical translation, regulatory pathways, and integration into healthcare systems. - Policy and public affairs: how industry standards, advocacy, and government collaboration shape responsible growth and patient access in this emerging field. - Takeaways: - PharmAla’s strategy centers on quality, regulatory rigor, and supply readiness for clinical and potential therapeutic use cases. - Industry maturation depends on robust…

In this episode, we sit down with Carolina Alarco, a senior biotech executive with over 25 years of experience in the biopharmaceutical industry. Carolina is the Founder & Principal of Bio Strategy Advisors, serves on multiple biotech and nonprofit boards, and is the Co-Founder & Co-Chair of Latinos in Bio.  She shares insights from her leadership journey at companies like Genzyme, Aegerion Pharmaceuticals, and Novelion Therapeutics, and discusses the future of biotech, the role of angel investing, and why diversity in innovation matters.  Tune in to hear how Carolina is shaping the next generation of biotech leaders and building a more inclusive innovation ecosystem.

In this episode, we are joined by Dr. Jason Hurt, a clinician-scientist and entrepreneur with extensive experience in radiopharmaceutical development, clinical trial strategy, and oncology drug development.  In March 2025, Dr. Hurt founded Theragnostic Insights, a consulting and strategic advisory firm focused on advancing theranostic solutions and radioligand therapies—pioneering approaches that are shaping the future of cancer treatment.

Robert serves as the CEO for medAppraise Inc., a health technology startup focused on transforming the health and wellness of employees in large industrial corporations through the use of a state-of-the-art musculoskeletal health evaluation solution. In addition, Robert currently serves as president of RNB Ventures Consulting Inc, which is a medical device/technology consultancy firm. RNB Ventures Consulting aim is to provide medical/clinical affairs consulting expertise to medical device and IV...

Ram is a serial entrepreneur with 25 years of experience in the ophthalmic pharmaceutical and device industry. Ramgopal is Inventor, Founder, and Chief Executive Officer of LensGen, Inc., a clinical-stage medical device company that is developing a novel intraocular lens for presbyopia. The Company has received support from one of the largest medical device companies in the world, and this led to LensGen closing a $28.0 million Series A Financing in May 2018. Currently, he is also Chairman of...

Laura Minarsch, R.T. RCIS, CVT, is a senior clinical affairs strategist and President of MMC Medical International Services. She consults for several novel innovative device companies in the MedTech space and has facilitated numerous acquisitions over her career spanning more than 25 years. Her track record is based on successful and strategically planned “First in Human” submissions and clinical studies in Europe, Canada, South America, New Zealand, and Australia. She has been instrumental in d...

Guy Vinograd is CEO at bio-T, a seasoned high-tech executive and an expert software architect of cloud platforms for medical devices. As an industry leader he is a popular speaker and the organizer of the meet-up group: Smart IoMT Product Experts of Israel. Guy has co-founded bio-T, the first and leading medical IoT cloud platform designed to enable medical device vendors to fully realize the potential of the data collected by their devices. Guy is considered a leading expert of Amazon Web...

Dr. Aklog is an adult heart surgeon/entrepreneur and Chairman & CEO of PAVmed Inc. (Nasdaq: PAVM), a multi-product medical device company which he co-founded based in 2014 on a portfolio of five of his own inventions. He previously co-founded Pavilion Holdings Group LLC which created four medical device companies including venture-backed Vortex Medical which developed and commercialized his life- saving invention AngioVac® and was sold in 2012 to Angiodynamics (Nasdaq: ANGO). Dr. Aklog receiv...

James F. Jordan is President/CEO at Pittsburgh Life Sciences Greenhouse and a healthcare professor at Carnegie Mellon University. Mr. Jordan is an accomplished Fortune 20-level executive with strong experience in the industry, consulting, and academia and is a recognized expert in market development and guiding the successful formation of entrepreneurial start-up businesses in the life sciences and healthcare industries. Prior to joining the PLSG, Mr. Jordan served as Senior Vice President of a ...